28th August 2014
« All Articles
Yulia Aspinall interviews ProQuest Dialog and Pi2 executives to find out more about the Pi2 acquisition and what the addition of this solution means for large and small pharmaceutical companies who need to access and manage product information or are involved in pharmacovigilance. The Q&A also looks at Pi2 systems such as the PinPoint Product Literature Database and the Drug Safety Triager.
Access to Jinfo articles and reports is a benefit of a Jinfo Subscription.
Please sign in here so that we can check your access to this item:
If this item has been shared with you by a colleague, please request a MyJinfo account.
Gain access to this article with a Jinfo Subscription. It will help your organisation:
Benefits and Pricing
Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
Claire LaybatsHead of Commercial Developmentclaire.firstname.lastname@example.org
About this article
Related Subscription Articles:
Related Blog items:
Back to top ^
Login to MyJinfo if you already have a Jinfo Subscription
"Intelligence systems - intelligence 2020"
In the 10 years plus we've been researching developments in news and current awareness, we've predicted and then seen a significant shift from current awareness to intelligence systems. (October - December 2019).
Research Focus »
... more items ...
Visit the Blog »
... more articles ...
... more reports ...
All Content »
© Jinfo Limited 1997-2019 · Cookies, Privacy, Legal